Relay Therapeutics Annual Revenue, Number of Employees, Growth and Funding

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$520M
Industry:Biotech
Founded:2016
Lead Investor(s):SoftBank Vision Fund
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Relay Therapeutics's estimated annual revenue is currently $20.5M per year.
  • Relay Therapeutics received $400.0M in venture funding in December 2018.
  • Relay Therapeutics's estimated revenue per employee is $155,000
  • Relay Therapeutics's total funding is $520M.

Employee Data

  • Relay Therapeutics has 132 Employees.
  • Relay Therapeutics grew their employee count by 40% last year.
  • Relay Therapeutics currently has 12 job openings.

Executive Contacts

NameTitle
Laura ShawverMember Board Of Directors
Donald BergstromHead Of R&d
Damian HoudePrincipal Scientist
Jessica CasalettoPrincipal Scientist, Biology
Levi PiercePrincipal Scientist
Katie OttoAssociate Director, Legal Services
Greg LahueAssociate Director, People Rewards
Sherri SmithAssociate Director DMPK
Arno VenterPrincipal Scientist
Ted PetersAssociate Director

Relay Therapeutics is building the world's first dedicated drug discovery platform centered on protein motion to discover and develop new medicines that will make a transformative difference for patients. By placing protein motion at the heart of drug discovery, Relay is pursuing what it believes will be a fundamental paradigm shift within the pharmaceutical industry, ushering in a new generation of drugs with the potential to improve and extend the lives of millions of patients. Headquartered in Cambridge, Mass., Relay Therapeutics is a private company launched in 2016. To date, Relay Therapeutics has raised $120M in financing from Third Rock Ventures, BVF Partners, GV (formerly Google Ventures), an affiliate of D.E. Shaw Research, Casdin Capital, EcoR1 Capital, Section 32 and Alexandria Venture Investments. Our world-class team is equal parts bright and bold, with a shared passion for working in intellectually stimulating environments. If you're creative, collaborative and passionate about making a difference in the lives of patients, join us!

keywords:Biotechnology,Healthcare,Pharmaceuticals

132

Number of Employees

$20.5M

Revenue (est)

12

Current Jobs

40%

Employee Growth %

$520M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$7.1M4659%N/A
Tango Therapeut...
$9M5841%N/A
Compass Therape...
$15.8M10215%N/A
Emulate
$14.7M95-17%N/A
Hamilton Storag...
$14.6M949%N/A
Alnylam Pharmac...
$74.9M122831%N/A
Axcella
$8.8M5719%N/A
Berkshire Corpo...
$11.5M7412%N/A
Repligen Corpor...
$50.2M32422%N/A
Allena Pharmace...
$6M5019%N/A

Relay Therapeutics News

09/03/2019 - Biotech IPO and M&A predictions from Jefferies analyst ...

More about Compass Therapeutics: The biotech company makes drugs ..... Relay Therapeutics: The Cambridge, Massachusetts-based biotech ...

09/08/2019 - Surges in R&D Jobs, VC Propel Massachusetts Biopharma ...

... three nine-figure deals: Moderna's pre-IPO $500 million in equity financing, completed in February 2018; Relay Therapeutics' $400 million in ...

09/03/2019 - Biopharma jobs boom in Massachusetts, though challenges ...

Moderna Therapeutics and Relay Therapeutics are both headquartered in Cambridge, and are responsible for the two biggest venture capital ...

Relay Therapeutics Funding

DateAmountRoundLead InvestorsReference
2016-09-15$57.0MAThird Rock Ventures, LLCArticle
2017-12-15$63.0MBBVF PartnersArticle
2018-12-21$400.0MCSoftBank Vision FundArticle

Relay Therapeutics Executive Hires

DateNameTitleReference
2017-04-05Sanjiv PatelPresident/CEOArticle
2017-07-25Deborah PalestrantVP Corporate Development & StrategyArticle
2017-11-16Sarah O?BrienVP Human ResourcesArticle
2018-04-05Don BergstromEVP/Head of Research and DevelopmentArticle
2018-12-05Mary Madervp chemistryArticle
2019-02-07Imogen PryceVP of Strategy and Corporate AffairsArticle